Preprint
Article

This version is not peer-reviewed.

Metabolic Syndrome Prevention Potential of Tamarillo: Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibition Before and After Digestion

A peer-reviewed article of this preprint also exists.

Submitted:

17 March 2025

Posted:

17 March 2025

You are already at the latest version

Abstract
Tamarillo (Solanum betaceum Cav.) is rich in polyphenols, anthocyanins, and carotenoids, making it a promising candidate for functional food development. Various parts of tamarillo were extracted using water and ethanol (0–95%), with 95% ethanol yielding the highest content of bioactive compounds in the peel, pulp, mucilage, and whole fruit, while 75% ethanol was more effective for the seeds. Among tamarillo components, the peel exhibited the highest concentrations of hydroxycinnamoyl derivatives, anthocyanins, and carotenoids, along with superior antioxidant capacity, including strong scavenging activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals (EC50, 45.26 µg extract/mL) and high reducing power (EC50, 113.3 µg extract/mL). Regarding enzyme inhibition relevant to metabolic syndrome (MetS), the peel extract exhibited the strongest inhibitory effects on α-glucosidase (IC50, 1.623 mg/mL) and angiotensin-converting enzyme (IC50, 1.435 mg/mL). In contrast, the pulp extract demonstrated the highest inhibitory activity against pancreatic lipase (IC50, 0.882 mg/mL) and α-amylase (IC50, 2.369 mg/mL). These findings suggest tamarillo extracts possess potent antioxidant activity and significant enzyme inhibitory properties, highlighting their potential as functional ingredients for MetS prevention. However, gastrointestinal digestion simulation influenced bioactive compound content and enzyme inhibition capacity. This study provides insights into developing tamarillo-based dietary supplements with optimized processing to preserve bioactive components.
Keywords: 
;  ;  ;  ;  ;  

1. Introduction

The prevalence of metabolic syndrome (MetS) has risen sharply in recent decades, posing a significant public health challenge [1]. One-fifth of adults in the United States and Europe are affected, with global prevalence estimates ranging from 12.5% to 31.4% [2]. Alarmingly, in 2020, approximately 3% of children and 5% of adolescents worldwide were also diagnosed with MetS [3], highlighting the increasing burden of this condition at an early age and the urgent need for MetS prevention.
MetS is a major driver of the global cardiovascular disease crisis, substantially increasing the risk of type 2 diabetes, cardiovascular disease, and premature death. It is characterized by interconnected cardiometabolic abnormalities, including hyperglycemia (insulin resistance), dyslipidemia (reduced serum high-density lipoprotein cholesterol and elevated triglycerides), and hypertension, often accompanied by abdominal obesity. The diagnosis of MetS requires the presence of at least three of these metabolic abnormalities [2,3,4].
In Taiwan, according to the Ministry of Health and Welfare, MetS-related diseases accounted for 27.4% of all deaths in 2023, based on the top ten leading causes of mortality. These included heart disease (excluding hypertensive diseases) (11.4%), cerebrovascular disease (6.0%), diabetes (5.7%), and hypertensive diseases (4.3%). Notably, this proportion was now comparable to that of malignant neoplasms (25.8%), underscoring the severe public health implications of MetS [5].
Beyond its impact on chronic disease prevalence and mortality, MetS imposes a substantial economic burden. Global healthcare expenditures and the loss of potential economic productivity related to MetS amount to trillions of dollars [1]. Currently, there is no single pharmacological treatment for MetS, and its management typically requires multiple medications. However, polypharmacy may lead to adverse effects and decreased patient adherence to medication [6]. Therefore, developing effective strategies for disease prevention has become a critical research priority. One promising approach is the development of functional foods specifically designed to mitigate the risk of MetS-related diseases.
Numerous studies have widely recognized fruits, vegetables, and other plant-based products as key dietary components for preventing MetS due to their abundance of phytochemicals, also known as natural bioactive compounds. Phytochemicals can be categorized into several classes based on their chemical structure and biological activity, including polyphenols, carotenoids, alkaloids, phytosterols, nitrogen-containing compounds, and organosulfur compounds. These plant-derived compounds exhibit diverse biological activities and provide various health benefits [6,7,8].
Oxidative stress has been strongly associated with the pathogenesis of numerous diseases, including MetS, cancer, atherosclerosis, malaria, Alzheimer’s disease, rheumatoid arthritis, neurodegenerative disorders, and preeclampsia [9]. Phytochemicals serve as potent antioxidants, which may help mitigate inflammation and oxidative stress [10]. Therefore, these compounds have demonstrated protective effects against various diseases, including obesity, diabetes, renal disorders, and cardiovascular disease [6,7]. Consequently, recent research has increasingly emphasized the important role of phytochemicals in mitigating MetS progression, highlighting their long-term beneficial effects in managing this condition [6,7,8]. Among phytochemicals, polyphenols have been the most extensively studied [6]. They have been reported to play a significant role in preventing the development of MetS by lowering plasma glucose levels, reducing blood pressure and body weight, and improving dyslipidemia [10,11,12]. Additionally, carotenoids have been suggested as important supportive compounds in treating MetS and other metabolic disorders [13].
Tamarillo, also known as the tree tomato (Solanum betaceum Cav. or Cyphomandra betacea Sendt.) [14,15], is native to South America and is cultivated in several other regions worldwide for its nutrient-rich fruit [16]. Tamarillo is a rich source of fiber, vitamin C, potassium, phenolic compounds, anthocyanins, carotenoids, and other phytochemicals while low in fat and sodium [16,17,18,19]. Moreover, it has a relatively high polyphenol content than other tropical fruits [16]. Due to its rich nutritional and bioactive composition, tamarillo has been proven to exhibit high antioxidant activity [17], suggesting its potential as a natural antioxidant with protective effects against metabolic syndrome [19] and cancer [20]. Additionally, different parts of the tamarillo plant exhibit variations in phytochemical composition and content [19]. Furthermore, tamarillo wastes and by-products have also been reported to contain a rich nutritional and bioactive composition [18]. This indicates tamarillo is abundant in phytochemicals, offering health benefits and potential protection against chronic diseases.
The health benefits of these phytochemicals depend on their purity. Therefore, they have significant applications after extraction, developing functional foods and nutraceuticals [21]. Moreover, the functionality of these bioactive compounds is influenced not only by their concentrations but also by their bioaccessibility and bioavailability after gastrointestinal digestion [22]. Understanding the factors that influence the bioavailability of phytochemicals is crucial for evaluating their biological significance and efficacy as functional food ingredients. Therefore, this study aimed to investigate the effects of extraction solvents and simulated gastrointestinal digestion on the phytochemical composition and bioactivity of different parts of tamarillo. First, the optimal water-to-ethanol ratio for extracting the highest amount of phytochemicals was determined, followed by an assessment of their antioxidant capacity and inhibitory effects on key enzymes associated with MetS, including pancreatic lipase (hyperlipidemia), α-amylase and α-glucosidase (hyperglycemia), and angiotensin-converting enzyme (ACE) (hypertension). Finally, a simulated gastrointestinal digestion model was employed to evaluate the impact of digestion on the phytochemical content in different parts of tamarillo and to determine whether digestion influences their enzyme inhibitory activity related to MetS.

2. Materials and Methods

2.1. Materials

Farmers in Nantou, Taiwan, donated red tamarillos (S. betaceum Cav.) and harvested 22–24 weeks post-anthesis at an altitude of 1,100–1,200 m above sea level. The fruit trees were five years old. Tamarillo fruits were stored at 4°C to 6°C, and their components were separated within a week. After being washed and drained, the fruits had their stems removed before being cut in half using a knife. The mucilage and seeds in the fruit’s center were scooped out with a small spoon, and the pulp was collected. The mucilage and seed mixture were then separated using fine mesh laundry bags.

2.2. Chemicals

Ethanol and methanol were purchased from Avantor Performance Materials (Radnor, PA, USA). Acetone, acarbose, α-amylase (from porcine pancreas, Type VI-B), α-carotene, α-glucosidase (from Saccharomyces cerevisiae), α-tocopherol, ascorbic acid, β-carotene, β-cryptoxanthin, butylated hydroxyanisole (BHA), captopril, chlorogenic acid, cyanidin-3-O-rutinoside, delphinidin-3-O-rutinoside, dimethyl sulfoxide (DMSO), 2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin–Ciocalteu phenol reagent, gallic acid, hippuric acid, hippuryl-L-histidyl-L-leucine (HHL), iron (III) chloride, lipase (from porcine pancreas, Type II), lycopene, orlistat, p-nitrophenyl-α-D-glucopyranoside (p-NPG), pancreatin (from porcine pancreas, 4 × USP specifications), pelargonidin-3-O-rutinoside, pepsin (from porcine gastric mucosa, 4711 U/mg protein), potassium ferricyanide, porcine bile extract, sodium chloride, starch (from potato), 3,5-dinitrosalicylic acid (DNS), trichloroacetic acid (TCA), Triton X-100, and ACE (from rabbit lung) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Rosmarinic acid and zeaxanthin were purchased from ChromaDex, Inc. (Irvine, CA, USA), and β-cryptoxanthin was obtained from Extrasynthese Co. (Genay Cedex, France). Sodium carbonate, sodium dihydrogen phosphate, and sodium phosphate were obtained from Union Chemical Works Ltd. (Hsinchu City, Taiwan). Ethyl acetate was purchased from Macron Fine Chemicals™ (Avantor, PA, USA), and n-hexane was obtained from Tedia Co. Inc. (Fairfield, OH, USA). Hydrochloric acid was purchased from Showa Chemical Co. Ltd. (Tokyo, Japan). Dialysis bags (molecular weight cut-off of 10,000 Da) were obtained from Membrane Filtration Products, Inc. (Seguin, TX, USA).

2.3. Sample Preparation and Extraction

The samples were subjected to vacuum freeze-drying using a freeze-dryer (FD-20L-6S, Kingmech Co., Ltd., New Taipei, Taiwan) under the following conditions: a vacuum pressure <0.2 mmHg, a chamber temperature of 25°C, and a condenser temperature of −50°C. Dried samples were ground using a mill (RT-30HS, Rong Tsong Precision Technology Co., Taichung, Taiwan) and passed through a 0.7 mm sieve. The resulting powders were sealed in PET/Al/PE laminated bags and stored at −25°C until further extraction.
The dried samples were extracted using water and ethanol at different concentrations (25%, 50%, 75%, and 95%) at a 1:10 (w/v) ratio in a 75°C water bath shaker (150 rpm) for 30 min. After centrifugation (8000 rpm, 10 min; 8060 ×g) using a centrifuge (Himac CR21G, Hitachi High-Technologies Co. Ltd., Minato-Ku, Tokyo, Japan) and filtration, the remaining residues were re-extracted with the same solvent under identical conditions. The supernatants from both extractions were pooled, concentrated under reduced pressure, and subjected to vacuum freeze-drying using a freeze dryer (N-1000, Rikakikai Co. Ltd., Tokyo, Japan). The resulting freeze-dried tamarillo extracts were designated 0E, 25E, 50E, 75E, and 95E.

2.4. Determination of Phytochemicals

2.4.1. Total Phenols

The sample solution preparation was modified based on Vasco et al.’s method (2009) [23]. Precisely weighed amounts of tamarillo freeze-dried extracts were used: 0.02 g of peel, 0.2 g of pulp and mucilage, 0.06 g of seeds, and 0.1 g of whole fruit. Each sample was mixed with 4 mL of 50% methanol and subjected to ultrasonic shaking for 15 min, followed by centrifugation (4000 rpm, 25°C; 2600 ×g) for 15 min. The supernatant was collected, while the residue was re-extracted with 70% acetone under the same conditions. The two supernatants were combined and diluted to a final volume of 10 mL with deionized water. The determination of total phenols was performed according to the method of Mau et al. (2017) [24].

2.4.2. Total Anthocyanins

The sample solution preparation was modified using Shao et al.’s method (2014a) [25]. A precisely weighed 0.3 g of freeze-dried tamarillo extract was placed in a test tube and extracted with 3 mL of methanol containing 1 M HCl using ultrasonic shaking for 15 min. The mixture was centrifuged at 5372 rpm (4000 ×g, 25°C) for 15 min. The supernatant was transferred to a separate test tube, and the extraction was repeated four additional times. The five supernatants were combined and diluted to a final volume of 20 mL with methanol containing 1 M HCl for analysis. Total anthocyanins were determined using the method of Mau et al. (2017) [24].

2.4.3. Total Carotenoids

The preparation and determination of total carotenoids were modified from the method of Knockaert et al. (2012) [26]. A precisely weighed 0.05 g of freeze-dried tamarillo extract from different parts, and the whole fruit was mixed with 4 mL of hexane: acetone: ethanol (2:1:1, v/v) and 1 mL of 10% KOH. The mixture was subjected to ultrasonic shaking for 15 minutes, followed by centrifugation (5000 rpm, 4°C; 3466 ×g) for 5 minutes. The supernatant was transferred to a test tube, and the extraction was repeated four additional times. The five supernatants were combined and diluted to a final volume of 25 mL with the extraction solvent for analysis. The determination of total carotenoids was performed according to Knockaert et al.’s method (2012).

2.4.4. Individual Phytochemicals

The sample preparation and determination of hydroxycinnamoyl derivatives, anthocyanins, and carotenoid content in freeze-dried extracts and digested extracts were performed according to Chen et al.’s method (2024) [19].

2.5. Determination of Antioxidant Activity

2.5.1. Determination of Scavenging Ability on DPPH

Freeze-dried tamarillo extracts and standard compounds, including ascorbic acid, BHA, and α-tocopherol, were precisely weighed, dissolved in 100% methanol, and diluted to appropriate concentrations. The scavenging ability of the samples against DPPH free radicals was analyzed according to Shimada et al.’s method (1992) [27], and both the scavenging activity and the median effective concentration (EC50) required to achieve 50% scavenging were calculated.

2.5.2. Determination of Reducing Power

Freeze-dried tamarillo extracts and standard compounds, including ascorbic acid, BHA, and α-tocopherol, were precisely weighed, dissolved in 100% methanol, and diluted to appropriate concentrations. The reducing power of the samples was analyzed according to Oyaizu et al.’s method (1986) [28], and both the reducing power and the EC50 were calculated.

2.6. Inhibitory Effects on Enzyme Activities

2.6.1. Pancreatic Lipase

For the pancreatic lipase inhibition assay, P95E, L95E, M95E, and W95E extracts (0.1 g each) and S75E extract (0.4 g) were weighed into glass test tubes and dissolved in 0.75 mL of 5% DMSO. The mixtures were sonicated for 20 min and then diluted to 5 mL with 5% DMSO, followed by centrifugation at 4000 rpm (≈2600 × g) for 15 min at 25 °C. The resulting supernatants had stock concentrations of 20 mg/mL for P95E, L95E, M95E, and W95E and 80 mg/mL for S75E. These stock solutions were further diluted with 5% DMSO to obtain a range of concentrations for the enzyme assay. Pancreatic lipase inhibitory activity was measured using a modified protocol based on McDougall et al. (2009) [29] and Luyen et al. (2013) [30], with orlistat as the positive control. Percentage inhibition at each sample concentration was recorded, and the half-maximal inhibitory concentration (IC₅₀) was calculated.

2.6.2. α-Amylase

For the α-amylase inhibition assay, P95E, L95E, M95E, and W95E extracts (0.12 g each) and the freeze-dried S75E extract (0.4 g) were weighed into test tubes and dissolved in 1 mL of 5% DMSO. The mixtures were sonicated for 15 min, then diluted to 5 mL with 0.02 M Na₂HPO₄ buffer (pH 6.9, containing 0.006 M NaCl) and centrifuged at 4000 rpm (2600 × g) for 15 min at 25 °C. The resulting supernatants had stock concentrations of 24 mg/mL for P95E, L95E, M95E, and W95E and 80 mg/mL for S75E. These stock solutions were further diluted with the same phosphate buffer to yield the required concentrations for the assay. α-Amylase inhibitory activity was measured using a modified method established by Pinto et al. (2010) [31], with acarbose as the positive control. The percentage inhibition at each concentration was determined, and IC₅₀ values were calculated.

2.6.3. α-Glucosidase

For the α-glucosidase inhibition assay, freeze-dried tamarillo extract (0.125 g) was dissolved in 1 mL of 5% DMSO and sonicated for 15 min. The mixture was diluted to 5 mL with 0.1 M phosphate-buffered saline (PBS, pH 6.9) and then centrifuged at 4000 rpm (2600 × g) for 15 min at 25 °C. The resulting supernatant had a stock concentration of 25 mg/mL, which was further diluted with the same PBS to prepare a range of concentrations for the assay. α-Glucosidase inhibitory activity was measured using a modified method established by Chiang et al. (2014) [32], with acarbose as the positive control. Percentage inhibition was measured at each concentration, and IC₅₀ values were calculated.

2.6.4. Angiotensin-Converting Enzyme (ACE)

For the ACE inhibition assay, freeze-dried tamarillo extract (0.09 g) was dissolved in 1 mL of 5% DMSO and sonicated for 15 min. The mixture was diluted to 5 mL with 300 mM NaCl buffer (pH 8.3) and centrifuged at 4000 rpm (2600 × g) for 15 min at 25 °C. The resulting supernatant had an approximate stock concentration of 18 mg/mL, and it was further diluted with the NaCl buffer to obtain various concentrations for the assay. ACE inhibitory activity was measured using a modified method established by Actis-Goretta et al. (2006) [33], with captopril as the positive control. The percentage inhibition at each concentration was determined, and IC₅₀ values were calculated.

2.7. Simulation of In Vitro Gastrointestinal Digestion and Analysis of Composition and Bioactivity

2.7.1. In Vitro Gastrointestinal Digestion

The in vitro gastrointestinal digestion process was simulated based on the methods established by Bouayed et al. (2011) [34] and Chiang et al. (2014) [32], with modifications. Tamarillo extracts underwent simulated gastric and intestinal phases, and the resulting digested samples, including the supernatant, insoluble residue, and dialysate fractions, were collected. These samples were analyzed for their bioactive components, including total phenols, total anthocyanins, and total carotenoids, as well as their inhibitory activity against metabolic syndrome-related enzymes.
In the gastric phase, 200 mg of tamarillo extract was mixed with 50 mL of 0.9% NaCl, 4 mL of 0.1 M HCl, and 4 mL of pepsin solution (20 mg/mL in 0.1 M HCl) in serum bottles. The mixture was incubated in a shaking water bath at 37°C for 1 h (100 rpm), maintaining a pH of 2.0–2.5.
In the intestinal phase, a 15.5 cm dialysis bag (molecular weight cut-off of 10 kDa) was pre-soaked in 0.9% NaCl solution, sealed at one end with a clip, and filled with 5.5 mL of NaCl and 5.5 mL of 0.5 M NaHCO₃. After removing air bubbles, the dialysis bag was sealed and immediately immersed in the gastric digest. The mixture was incubated in a shaking water bath at 37°C for 45 min (100 rpm) to simulate the transition from the gastric to the intestinal phase, during which the pH was adjusted to approximately 6.5. Subsequently, 18 mL of a pancreatin and porcine bile extract mixture (2 mg/mL pancreatin, 12 mg/mL bile extract dissolved in 0.1 M NaHCO₃) was added, and digestion continued in the shaking water bath at 37°C for 2 h (100 rpm), with the final pH maintained at 7.0–7.5. After digestion, the mixture was centrifuged at 10,000 ×g for 20 min to separate the soluble supernatant and the insoluble precipitate. The collected fractions were stored at −20°C to further analyze bioactive compounds, antioxidant capacity, and enzyme inhibition activity. The fraction diffused into the dialysis bag was considered the serum-available portion, representing compounds that could potentially enter systemic circulation [35].

2.7.2. Determination of Phytochemicals in Digested Extracts

2.7.2.1. Total Phenols

The sample preparation and determination followed the method described in Section 2.4.1, with slight modifications in sample weight. The weights of the dialysate samples were 0.07 g for P95E, 0.3 g for L95E and M95E, 0.2 g for S75E, and 0.2 g for W95E. For the intestinal supernatant, the weights were 0.06 g for P95E and 0.4 g for L95E, M95E, S75E, and W95E. The weights of the intestinal precipitate were 0.012–0.015 g for P95E, 0.013 g for L95E, 0.011 g for M95E, 1.00–1.22 g for S75E, and 0.011–0.012 g for W95E.

2.7.2.2. Total Anthocyanins

The sample preparation and determination followed the method described in Section 2.4.2, with adjustments to the sample weight. The weights of the dialysate samples were 0.23 g for P95E, 0.3 g for L95E, S75E, and W95E, and 0.273 g for M95E. For the intestinal supernatant, the weight was 0.3 g for freeze-dried digested samples from all tamarillo parts. The weights of the intestinal precipitate were 0.024 g for P95E, 0.067 g for L95E, 0.055 g for M95E, 0.2 g for S75E, and 0.054 g for W95E.

2.7.2.3. Total Carotenoids

The sample preparation and determination followed the method described in Section 2.4.3, with modifications in sample weight. The dialysate and intestinal supernatant samples were weighted 0.1 g for freeze-dried digested material from all tamarillo parts. The weights of the intestinal precipitate were 0.022 g for P95E, 0.05 g for L95E, M95E, and S75E, and 0.043 g for W95E.

2.7.3. Inhibitory Effects on Enzyme Activities

The determination followed the method described in Section 2.6.

2.8. Statistics

Each measurement was performed in triplicate. The variance in the experimental data was analyzed by analysis of variance using the Statistical Analysis System software package (SAS Institute, Cary, NC, USA). Duncan’s multiple range test was used to determine the significance of differences among the means at the 0.05 level.

3. Results and Discussion

This study utilized various ratios of binary extraction solvents (water and ethanol) to extract bioactive compounds from different parts of tamarillo. The extract yield and bioactive compound content were determined. The extraction conditions yielding the highest bioactive compound content were selected for further investigation, including identifying individual bioactive compounds and their antioxidant activity and inhibitory effects on enzymes related to MetS prevention. Furthermore, to evaluate the impact of gastrointestinal digestion on the biochemical composition and bioactivity of the extracts, an in vitro gastrointestinal digestion simulation was conducted. This approach provides a more comprehensive understanding of the potential physiological effects of different tamarillo components after digestion in the human gastrointestinal tract. Ultimately, this study aims to determine the optimal processing methods to maximize the bioavailability of tamarillo as a functional supplement, ensuring its efficacy in preventing MetS.

3.1. The Yield of Extraction

The diverse structures of bioactive compounds, along with their varying polarity and solubility, can complicate the extraction process [36]. Therefore, the extraction method must be carefully optimized for safety and environmental sustainability. In the food industry, the choice of extraction solvents should ensure high efficiency and comply with safety and sustainability standards, making green extraction solvents a preferred option [37]. Moreover, a single solvent is often insufficient to efficiently extract all bioactive compounds from plant materials. As a result, binary solvent systems, such as water–organic solvent mixtures, are commonly employed to enhance the extraction of both polar and non-polar compounds, thereby improving overall yield and efficiency [38].
This study extracted freeze-dried tamarillo powder from different fruit parts using water and ethanol in varying ratios (0%, 25%, 50%, 75%, and 95% ethanol). As shown in Table S1, the extraction yield of different tamarillo parts decreased as ethanol concentration increased. When extracted with water alone (0E), peel, pulp, mucilage, seeds, and whole fruit yield 26.72%, 65.16%, 92.86%, 17.81%, and 57.64%, respectively. However, as the ethanol concentration increased to 95% (95E), the extraction yields decreased to 11.21%, 41.17%, 56.49%, 6.67%, and 33.68%, respectively.

3.2. Bioactive Compounds

The total phenols, anthocyanins, and carotenoids contents in tamarillo extracts from different fruit parts obtained using various water-to-ethanol ratios were analyzed, and the results are presented in Figure 1. Unlike the extraction yield, which decreased as ethanol concentration increased, the concentrations of these three bioactive compounds exhibited an increasing trend with higher ethanol ratios.

3.2.1. Total Phenols

The total phenols content of freeze-dried tamarillo extracts from different fruit parts is presented in Figure 1A. Except for seeds, which exhibited the highest total phenols content at 75% ethanol (75E, 48.31 mg GAE/g freeze-dried extract), all other fruit parts showed the highest levels at 95% ethanol (95E). The total phenols content followed the order peel (153.0 mg GAE/g) > whole fruit (34.64) > pulp (21.19) > mucilage (19.85).

3.2.2. Total Anthocyanins

As the ethanol concentration in the extraction solvent increased, the total anthocyanins content in the freeze-dried extracts of different tamarillo parts also increased, with the highest levels generally observed at 95E (Figure 1B). The total anthocyanins content (mg C3GE/g freeze-dried extract) was of the order: mucilage (8.140) > peel (5.600) > whole fruit (3.674) > seeds (2.195) > pulp (1.110).

3.2.3. Total Carotenoids

As shown in Figure 1C, the total carotenoid content in freeze-dried tamarillo extracts increased with higher ethanol concentrations, with the highest levels generally observed at 95E, except for seeds, which exhibited the highest content at 75E (0.982 mg βCE/g freeze-dried extract). At 95E, the total carotenoids content (mg βCE/g freeze-dried extract) in different fruit parts was in the descending order of peel (4.324) > pulp (1.174) > whole fruit (0.771) > mucilage (0.466).

3.2.4. Optimal Extraction Conditions

Based on the experimental results, 95% ethanol was the optimal extraction condition for freeze-dried tamarillo peel, pulp, mucilage, and whole fruit, yielding the highest levels of bioactive compounds. In contrast, 75% ethanol was more effective for extracting bioactive compounds from seeds. Therefore, tamarillo extracts obtained using 95% ethanol for peel (P95E), pulp (L95E), mucilage (M95E), and whole fruit (W95E), as well as the extract obtained using 75% ethanol for seeds (S75E), were selected for further analysis to evaluate their antioxidant capacity and enzyme inhibitory effects related to MetS prevention.

3.3. Individual Bioactive Compounds

3.3.1. Hydroxycinnamoyl Derivatives

The chlorogenic acid content (mg/g freeze-dried extract) in the freeze-dried extracts of different tamarillo parts followed the order P95E (74.90) > W95E (9.234) > L95E (5.707) > S75E (1.868) ≈ M95E (1.696) (Table 1). Similarly, rosmarinic acid content (mg/g freeze-dried extract) was significantly higher in P95E (66.69) than in other parts, followed by W95E (6.697), with the lowest content observed in M95E (0.242). When combining chlorogenic acid and rosmarinic acid, the total hydroxycinnamoyl derivatives content (mg/g freeze-dried extract) was highest in P95E (141.6), followed by W95E (15.93) > L95E (8.934) > S75E (3.412) > M95E (1.938), accounting for 92.55%, 45.99%, 42.16%, 7.06%, and 9.76% of the total phenols content (Figure 1) in the respective extracts. When recalculated based on extraction yield, the total hydroxycinnamoyl derivatives content (mg/g freeze-dried sample) in P95E, L95E, M95E, S75E, and W95E was 15.87, 3.678, 1.094, 0.2146, and 5.365, respectively. Notably, the whole fruit extract (536.5 mg/100 g freeze-dried sample) exhibited a higher total hydroxycinnamoyl derivatives content compared to the Giant Purple cultivar (132.6 ± 0.909 mg/100 g dry weight) and the New Zealand Purple cultivar (421.6 ± 3.082 mg/100 g dry weight) of tamarillo, as reported by Espín et al. (2016) [39].

3.3.2. Anthocyanins

The individual anthocyanin content in freeze-dried extracts of different tamarillo parts is presented in Table 1. Among mucilage, seeds, and whole fruit, delphinidin-3-O-rutinoside was the most abundant anthocyanin, with 6.606, 4.179, and 2.186 mg/g freeze-dried extract, respectively. In contrast, cyanidin-3-O-rutinoside was predominant in the peel (8.687 mg/g freeze-dried extract), while pelargonidin-3-O-rutinoside was most abundant in the mucilage (6.111 mg/g freeze-dried extract). Regarding total anthocyanins content (mg/g freeze-dried extract), mucilage exhibited the highest levels (13.39), followed by peel (10.64) > seeds (7.630) > whole fruit (5.005) > pulp (0.625). Anthocyanins in pulp and seeds may be attributed to residual mucilage. When recalculated based on extraction yield, the total anthocyanins content (mg/g freeze-dried sample) in P95E, L95E, M95E, S75E, and W95E was 1.193, 0.257, 7.560, 0.480, and 1.686, respectively. These values were higher than those reported by Espín et al. (2016) [39] for the purple tamarillo cultivars from Ecuador and New Zealand.

3.3.3. Carotenoids

The carotenoid content in tamarillo extracts is shown in Table 1. The peel extract contained the highest levels of β-cryptoxanthin (0.928) and β-carotene (0.942). The β-cryptoxanthin was also the predominant carotenoid in all other parts, with concentrations (mg/g freeze-dried extract) following the order L95E (0.240) ≈ W95E (0.238) > M95E (0.085) > S75E (0.061). Additionally, only β-cryptoxanthin and β-carotene were detected in M95E, whereas S75E contained β-cryptoxanthin and zeaxanthin. Notably, lycopene and α-carotene were not detected in any extract. The total carotenoid content (mg/g freeze-dried extract) followed the order P95E (1.943) > L95E (0.431) > W95E (0.318) > M95E (0.136) > S75E (0.069). These results align with findings from [40,41], which reported that β-cryptoxanthin and β-carotene are the primary carotenoids in tamarillo.

3.4. Antioxidation Properties

3.4.1. DPPH Radical-Scavenging Ability

The DPPH radical-scavenging capacity of freeze-dried tamarillo extracts from different fruit parts and whole fruit is presented in Figure S1A. As the extract concentration increased, the DPPH scavenging activity also increased. At a low concentration (50 μg/mL), the scavenging capacity followed the order P95E (55.24%) > S75E (17.74%) > W95E (14.30%) > L95E (10.09%) > M95E (8.66%). P95E exhibited the highest scavenging activity, exceeding 90% at 100 μg/mL. The EC50 values (μg extract/mL) for DPPH scavenging activity are presented in Table 2. The lowest EC50 value (μg extract/mL), indicating the strongest antioxidant activity, was observed in P95E (45.26), followed by S75E (181.6) > W95E (221.0) > L95E (388.2) ≈ M95E (386.4). When recalculated based on total phenols content, the EC50 values (μg total phenols/mL) were P95E (9.420) > S75E (10.27) > W95E (12.24) > M95E (14.93) > L95E (15.57). Tamarillo extract showed a strong DPPH radical-scavenging ability compared to standard antioxidants ascorbic acid (15.60 μg/mL), BHA (17.51μg/mL), and α-tocopherol (16.35 μg/mL).

3.4.2. Reducing Power

The reducing power of freeze-dried tamarillo extracts from different fruit parts and whole fruit is presented in Figure S1B. As the extract concentration increased, the reducing power also increased. At a low concentration (200 μg/mL), the reducing power (absorbance at 700 nm) followed the order P95E (0.873 AU) > W95E (0.179 AU) ≈ S75E (0.175 AU) > M95E (0.119 AU) ≈ L95E (0.117 AU). The EC50 values for the reducing power assay are presented in Table 2. The lowest EC50 value (μg extract/mL), indicating the highest reducing capacity, was observed in P95E (113.3 μg/mL), followed by S75E (597.2 μg/mL) > W95E (618.8 μg/mL) > M95E (938.4 μg/mL) > L95E (956.7 μg/mL). When recalculated based on total phenols content (μg total phenols/mL), the reducing power followed the order P95E (23.58) > S75E (33.77) > W95E (34.27) > M95E (36.26) > L95E (38.37). All extracts' reduced capacity (EC50 value) was significantly stronger than α-tocopherol (118.3 μg/mL). Additionally, P95E, S75E, and W95E exhibited stronger reducing power than BHA (34.98 μg/mL), though all extracts showed lower reducing capacity than ascorbic acid (19.82 μg/mL).
The results of this study demonstrate that tamarillo extracts exhibit strong antioxidant capacity, as evidenced by their DPPH radical-scavenging activity and reducing power. P95E consistently exhibited the highest antioxidant potential among the tested extracts, with the lowest EC50 values in both assays, followed by S75E and W95E. The strong antioxidant activity of tamarillo extracts can be attributed to their rich bioactive compounds, particularly hydroxycinnamoyl derivatives, anthocyanins, and carotenoids, which are known for their free radical-scavenging and redox properties. Given the well-established link between oxidative stress and inflammation-related diseases [17,42], these findings suggest tamarillo extracts may possess anti-inflammatory properties. Moreover, since oxidative stress is a key factor in developing metabolic syndrome, the potent antioxidant activity observed in tamarillo extracts highlights their potential as functional food ingredients for MetS prevention.

3.5. Enzyme Inhibitory Activity

Hyperlipidemia, hyperglycemia, and hypertension are key indicators of MetS. Therefore, this study evaluated the ability of tamarillo extracts from different parts of the fruit to inhibit key enzymes associated with these conditions, including pancreatic lipase (involved in fat digestion and absorption), α-amylase and α-glucosidase (involved in carbohydrate hydrolysis), and ACE (related to blood pressure regulation). Furthermore, the inhibitory effects of tamarillo extracts were compared with commercially available medications to assess their potential in preventing MetS.

3.5.1. Pancreatic Lipase Inhibitory Activity

Pancreatic lipase plays an important role in fat digestion and absorption, and its inhibition has been linked to potential anti-obesity effects [43]. Polyphenols, anthocyanins, and carotenoids have been reported to inhibit pancreatic lipase activity, thereby contributing to weight management [44,45,46]. This study evaluated the pancreatic lipase inhibitory capacity of freeze-dried tamarillo extracts derived from different fruit parts and the whole fruit. Except for the seed extract, all tamarillo extracts exhibited a dose-dependent inhibition of pancreatic lipase, with inhibition increasing as extract concentration increased (Figure S2). At a low concentration (1 mg/mL), the inhibitory effects of the tamarillo extracts followed the order L95E (56.68%) > M95E (34.57%) > W95E (31.75%) > P95E (6.390%) > S75E (0%). At 3 mg/mL, L95E achieved 90% inhibition, whereas M95E and W95E required a higher concentration of 4 mg/mL to surpass 90% inhibition. In contrast, S75E exhibited no inhibition at 5 mg/mL; even at 20 mg/mL, its inhibition rate remained relatively low at 59.81% (Figure S2B). The IC50 values (the concentration required to inhibit 50% of enzyme activity) for tamarillo extracts and orlistat are presented in Table 3, with inhibitory potency ranking as follows: Orlistat (9.066 ng/mL) > L95E (0.882 mg/mL) > M95E (1.637 mg/mL) > W95E (1.861 mg/mL) > P95E (2.964 mg/mL) > S75E (16.67 mg/mL). These findings indicate that orlistat exhibits significantly higher pancreatic lipase inhibitory activity than tamarillo extracts. However, the consumption of orlistat has been associated with adverse side effects such as fecal incontinence, bloating, and steatorrhea [47].

3.5.2. α-Amylase and α-Glucosidase Inhibitory Activity

α-Amylase and α-glucosidase are key carbohydrate-digesting enzymes associated with postprandial hyperglycemia in individuals with type 2 diabetes. α-Amylase catalyzes the cleavage of α-1,4-glycosidic bonds, breaking down polysaccharides into smaller oligosaccharide fragments, while α-glucosidase further hydrolyzes these oligosaccharides into glucose. Inhibiting these enzymes can slow carbohydrate digestion and absorption, thereby helping to regulate postprandial blood glucose levels [48,49,50]. Additionally, phenolic acids, anthocyanins, and carotenoids have been reported to inhibit α-amylase and α-glucosidase activities, suggesting their potential role in glycemic control [51,52,53].
The α-amylase inhibitory activity of freeze-dried tamarillo extracts is presented in Figure S3. The inhibition rate increased with extract concentration, demonstrating a dose-dependent effect. At 1 mg/mL, the α-amylase inhibition of tamarillo extracts followed the order W95E (6.419%) > L95E (5.387%) ≈ M95E (4.954%) > S75E (2.966%) > P95E (1.685%). At 3 mg/mL, L95E exhibited over 90% inhibition of α-amylase activity. For W95E and M95E, the concentrations required to achieve 90% inhibition were 4 mg/mL and 5 mg/mL, respectively. P95E showed a rapid increase in α-amylase inhibition between 5 mg/mL and 6 mg/mL, rising from 27.32% to 89.02% (Figure S3A). Meanwhile, S75E required 15 mg/mL and 20 mg/mL concentrations to reach inhibition rates of 47.12% and 86.91%, respectively (Figure S3B). The IC50 values for tamarillo extracts and acarbose, a commercial α-amylase inhibitor, are shown in Table 3. The inhibitory potency followed the order acarbose (5.525 μg/mL) > L95E (2.369 mg/mL) > W95E (3.132 mg/mL) > M95E (3.351 mg/mL) > P95E (5.368 mg/mL) > S75E (14.80 mg/mL). These results indicate that acarbose exhibits significantly stronger α-amylase inhibitory activity than tamarillo extracts.
The α-glucosidase inhibitory activity of freeze-dried tamarillo extracts from different fruit parts and the whole fruit is shown in Figure S4. The inhibitory effect increased with extract concentration, demonstrating a dose-dependent response. At a low concentration (2 mg/mL), the inhibition rates of tamarillo extracts followed the order P95E (61.62%) > S75E (37.48%) > W95E (17.00%) > L95E (2.792%) > M95E (0%). At 10 mg/mL, the inhibition rates for different tamarillo parts were as follows: peel (96.80%) > seeds (75.31%) > whole fruit (72.50%) > pulp (70.35%) > mucilage (57.33%). The IC50 values (Table 3), representing the concentration required to inhibit 50% of α-glucosidase activity, followed the order acarbose (91.21 μg/mL) > P95E (1.623 mg/mL) > S75E (3.581 mg/mL) > W95E (5.534 mg/mL) > L95E (6.299 mg/mL) > M95E (8.856 mg/mL).
Acarbose is a commonly prescribed drug for type 2 diabetes that inhibits both α-amylase and α-glucosidase, slowing glucose absorption and reducing postprandial blood sugar spikes. Indeed, the IC50 values of acarbose for inhibiting α-amylase and α-glucosidase were significantly lower than those of tamarillo extracts, indicating its superior inhibitory potency. However, acarbose consumption has been associated with adverse side effects such as abdominal discomfort, diarrhea, bloating, and hepatotoxicity [54,55].

3.5.3. ACE Inhibitory Activity

The renin-angiotensin system regulates blood pressure, cardiac function, and vascular homeostasis. Renin catalyzes the conversion of angiotensinogen into angiotensin I, which is subsequently cleaved by ACE to generate angiotensin II, a potent vasoconstrictor. Inhibiting ACE activity is a well-established strategy for managing hypertension [56]. Polyphenols, anthocyanins, and carotenoids have been reported to contribute to ACE inhibition, demonstrating potential antihypertensive effects [57,58,59].
The ACE inhibitory activity of freeze-dried tamarillo extracts is presented in Figure S5. The inhibition rate increased with extract concentration, exhibiting a dose-dependent effect. At a low concentration (1 mg/mL), the ACE inhibition rates followed the order P95E (42.73%) ≈ S75E (42.65%) > W95E (26.46%) ≈ M95E (24.58%) > L95E (15.39%). At 6 mg/mL, the inhibition rates increased to P95E (87.12%) > S75E (83.26%) ≈ W95E (81.05%) ≈ M95E (78.47%) ≈ L95E (75.40%). The IC50 values (Table 3), representing the concentration required to inhibit 50% of ACE activity, followed the order captopril (0.481 ng/mL) > P95E (1.435 mg/mL) ≈ S75E (1.417 mg/mL) > W95E (3.479 mg/mL) ≈ M95E (3.587 mg/mL) > L95E (4.038 mg/mL).
Captopril, a widely used antihypertensive drug, effectively inhibits ACE activity. As evidenced by the results, the IC50 value of captopril was significantly lower than those of tamarillo extracts, indicating its superior inhibitory potency. However, the use of captopril has been associated with adverse side effects, including chronic cough, taste disturbances, and skin rashes [60].
These findings suggest that freeze-dried tamarillo extracts have the potential for anti-obesity effects and the prevention of type 2 diabetes and hypertension. Although their inhibitory effects were not as strong as those of pharmaceutical drugs, concerns remain regarding the side effects associated with drug use. Consequently, there is growing interest in natural, food-based alternatives for inhibiting enzymes related to MetS, positioning tamarillo extracts as promising functional ingredients for its prevention.

3.6. Bioactive Compounds After Simulated In Vitro Gastrointestinal Digestion

Based on the findings of this study, tamarillo extracts are rich in bioactive compounds and exhibit strong inhibitory activity against enzymes associated with MetS. However, upon ingestion, these bioactive compounds undergo gastrointestinal digestion, during which they may be modified or degraded by digestive enzymes [61]. Therefore, understanding the effects of simulated digestion on these compounds' bioactivity, bioaccessibility, and bioavailability is essential for further research, particularly in developing strategies to enhance their stability and functionality [62]. This knowledge can also support the development of targeted delivery techniques, facilitating the formulation of functional ingredients and determining effective dosages [63]. In this study, freeze-dried tamarillo extracts were subjected to simulated in vitro gastrointestinal digestion to evaluate changes in the content and bioactivity of bioactive compounds before and after digestion. Following the digestion simulation, the supernatant was collected as the soluble fraction, while the precipitate represented the insoluble portion. The dialysate inside the dialysis bag was also collected for analysis, as this fraction represents the compounds that have entered the bloodstream. This fraction is crucial, as it defines the bioavailability of the compounds, indicating their potential to exert physiological functions [64,65].

3.6.1. Total Polyphenols

The total phenols content (mg GAE/200 mg freeze-dried extract) of tamarillo extracts before and after simulated in vitro gastrointestinal digestion is presented in Table 4. Among the intestinal supernatants (soluble fraction), P95E exhibited the highest total phenols content (34.32), followed by S75E (11.87) > W95E (10.28) > L95E (7.188) ≈ M95E (7.113). Notably, the total phenols content in the soluble fraction was significantly increased compared to the non-digested extracts. In contrast, the intestinal precipitate (insoluble fraction) showed a marked decrease in total phenols content relative to the non-digested extracts, with S75E having the highest content at 1.541 mg GAE, representing only 15.95% of its pre-digestion level. Similar observations have been reported in the literature. For instance, He et al. (2017) found that the total phenols content increased after digestion in 22 types of fruit juices [66], while Hwang et al. (2023) noted that cherry tomatoes maintained their phenols content during gastric digestion but experienced a significant reduction following intestinal digestion [67]. These findings underscore the sensitivity of phenolic compounds to the gastrointestinal environment. Phenolic compounds are highly responsive to pH changes; they tend to remain stable under mildly acidic conditions, such as those in the stomach but are prone to degradation in the more alkaline conditions of the small intestine [68]. This degradation may be further influenced by interactions between hydrolyzed polyphenols and proteins and the conversion of certain polyphenols into their respective breakdown products during intestinal digestion [69,70]. The study results indicate that the total phenols content in the dialysate significantly decreased after simulated gastrointestinal digestion. The total phenols content (mg GAE/200 mg freeze-dried extract) in the dialysate for P95E, L95E, M95E, S75E, and W95E was 3.168, 0.793, 0.746, 1.146, and 1.025, respectively. During the dialysis phase, only 10.36–18.79% of the total phenolic compounds could pass through the dialysis membrane, suggesting that only a small fraction of polyphenols can reach the bloodstream. The permeability of polyphenols through the dialysis membrane depends on several factors, including molecular size, degree of polymerization, and the presence of sugar moieties. Generally, monomeric or glycosylated derivatives are more likely to pass through the membrane than their polymerized counterparts [71]. These findings highlight the potential challenges in the bioavailability of polyphenols and underscore the importance of further research into strategies for enhancing their absorption and physiological effectiveness.

3.6.2. Total Anthocyanins

The health benefits of anthocyanins depend highly on their bioavailability after digestion, which is influenced by their source, dosage, and the experimental model. Numerous studies on anthocyanin-rich food consumption have demonstrated that only a small fraction of ingested anthocyanins are absorbed intact into the bloodstream or excreted in the urine [72]. After oral ingestion, anthocyanins remain stable in the stomach's acidic environment (pH 1.5–5.0), where some may be absorbed. However, upon entering the intestine, exposure to higher pH levels (pH 5.6–7.9), enzymatic activity, and gut microbiota metabolism contribute to their extensive degradation, further limiting their absorption into the bloodstream [72,73]. As a result, a substantial portion of anthocyanins is lost during digestion, significantly reducing their bioavailability. Our findings (Table 4) further confirm the significant decline in total anthocyanin content after digestion. In the intestinal supernatant, detectable levels of total anthocyanins were observed only in P95E and M95E, with concentrations of 0.589 mg C3GE/200 mg freeze-dried extract, and 1.406 mg C3GE/200 mg freeze-dried extract, corresponding to 52.59% and 86.36% of their pre-digestion content, respectively. However, no anthocyanins were retained in the intestinal precipitate, indicating their complete degradation or solubilization during digestion. Additionally, anthocyanin permeability through the dialysis membrane, which simulates potential absorption into the bloodstream, was detected in P95E, L95E, M95E, S75E, and W95E, with concentrations of 0.176, 0.021, 0.267, 0.063, and 0.068 mg C3GE/200 mg freeze-dried extract, respectively. This suggests that only 9.25% to 16.40% of the anthocyanins were potentially bioavailable for systemic circulation. Similarly, Yamazaki et al. reported that only 10–20% of anthocyanins are actively transported into the bloodstream through gastric epithelial cells, primarily in the form of their metabolites [74]. These findings highlight the substantial loss of anthocyanins during digestion and their limited bioavailability, emphasizing the need for strategies to enhance their stability and absorption.

3.6.3. Total Carotenoids

The total carotenoid content of tamarillo extracts before and after in vitro gastrointestinal digestion simulation is presented in Table 4. In the intestinal supernatant, P95E exhibited the highest carotenoid content (0.435 mg βCE/200 mg freeze-dried extract), retaining 50.29% of its pre-digestion level, whereas S75E had the lowest content (0.038 mg βCE/200 mg freeze-dried extract), retaining only 20.43%. In the intestinal precipitate, the carotenoid content across different tamarillo extracts ranged from 0.003 to 0.067 mg βCE/200 mg freeze-dried extract, accounting for only 1.95–7.75% of the initial amount. Furthermore, only 9.36–17.53% of the total carotenoids from P95E, L95E, M95E, S75E, and W95E could pass through the dialysis membrane, which simulates potential absorption into the bloodstream. The concentrations detected in the dialysate were 0.081, 0.024, 0.016, 0.020, and 0.027 mg βCE/200 mg freeze-dried extract. These findings indicate that only a small fraction of carotenoids is bioavailable after digestion. Carotenoids are extremely sensitive to various environmental factors, including light exposure, oxidation, and pH fluctuations. Acidic conditions, in particular, significantly accelerate their decomposition, whereas degradation tends to be lower at pH values ranging from 6.0 to 7.0 [67]. Therefore, the acidic environment of gastric juice may influence the stability and subsequent uptake of β-carotene [75]. These results align with our findings, demonstrating a significant decline in total carotenoid content following digestion simulation and confirming that only a limited portion of carotenoids is available for systemic circulation.

3.7. Enzyme Inhibitory Activity of Dialysate After Simulated In Vitro Gastrointestinal Digestion

Phytochemicals are susceptible to chemical degradation when exposed to environmental factors such as pH fluctuations, heat, light, oxygen, and prooxidants [76]. Similarly, polyphenols from different plant sources or types exhibit varying compositional and bioactivity changes after simulated gastrointestinal digestion. These variations are influenced by multiple factors, including the inherent chemical structures of phytochemicals and the food matrix, which collectively impact their stability and bioavailability [77,78]. Hwang and Kim (2023) reported a significant reduction in total polyphenols, flavonoids, carotenoids, and antioxidant capacity in cherry tomatoes after in vitro gastrointestinal digestion [67]. However, other studies have shown that despite digestion, certain plant infusions still retained their antioxidant potential and the ability to inhibit α-amylase, α-glucosidase, and ACE, suggesting their potential antidiabetic and antihypertensive effects [77].
The IC50 values for inhibiting pancreatic lipase, α-amylase, α-glucosidase, and ACE in the dialysis phase of in vitro digested tamarillo extracts are presented in Table 5. The results indicate a significant increase in IC50 values across all enzyme assays, suggesting that digestion reduces the biochemical activity of tamarillo extracts. A comparison of different fruit parts revealed varying degrees of increase in IC50 values after digestion. P95E exhibited the highest increase (approximately 8.2–9.0 times), followed by S75E and W95E (6.5–6.9 times and 5.8–6.4 times, respectively). L95E and M95E showed the lowest increase (approximately 4.9–5.2 and 4.9–5.3 times, respectively). These findings suggest that the resistance of tamarillo extracts to digestive degradation varies among different fruit parts. The pulp and mucilage retained the highest biochemical activity, whereas the peel exhibited the lowest retention. Nevertheless, all extracts retained some degree of inhibition against pancreatic lipase, α-amylase, α-glucosidase, and ACE, which are key enzymes involved in obesity, hyperglycemia, and hypertension. These results highlight the potential of tamarillo extracts as functional ingredients, as they retain partial effectiveness in preventing metabolic syndrome even after digestion.
This study initially optimized the extraction conditions for different tamarillo fruit parts using a water-ethanol solvent mixture, revealing that the extracts were rich in polyphenols, anthocyanins, and carotenoids. These bioactive compounds exhibited strong antioxidant activity and significant inhibitory effects on pancreatic lipase, α-amylase, α-glucosidase, and ACE, suggesting that tamarillo may offer potential benefits in preventing obesity, hyperglycemia and hypertension, thereby contributing to the prevention of MetS.
Our findings align with previous studies indicating that total polyphenols, anthocyanins, carotenoids, and biochemical activities in plants are affected by digestion to varying degrees. This study specifically analyzed the soluble, insoluble, and dialysis phases post-digestion. While most tamarillo extracts exhibited reduced total polyphenols, anthocyanins, and carotenoids after digestion, the soluble phase contained a higher total polyphenols content than the undigested extracts, suggesting improved polyphenols solubility during digestion.
Since the dialysis phase represents bioavailable compounds capable of entering the bloodstream, we further evaluated its ability to inhibit pancreatic lipase, α-amylase, α-glucosidase, and ACE. The results showed that the IC50 values for these enzymes were significantly higher than those of the undigested extracts, indicating that digestion and absorption reduce overall biochemical activity. Nevertheless, the extracts retained some inhibitory effects on these key enzymes associated with MetS, suggesting they still hold potential for MetS prevention.
This study underscores the importance of considering the effects of gastrointestinal digestion and systemic absorption on the bioactivity of plant-derived compounds. Food processing technologies such as microencapsulation should be explored to enhance their bioavailability and stability. These strategies could improve the functional efficacy of tamarillo extracts as potential dietary supplements or functional foods for metabolic syndrome prevention.

4. Conclusions

This study investigated tamarillo extracts' phytochemical composition, antioxidant capacity, and enzyme inhibitory effects, assessing the impact of different extraction solvents and simulated gastrointestinal digestion. The results demonstrated that ethanol concentration significantly influenced the extraction efficiency of bioactive compounds, with 95% ethanol yielding the highest levels of polyphenols, anthocyanins, and carotenoids in most fruit parts. Tamarillo extracts exhibited strong antioxidant activity and notable inhibitory effects against key metabolic syndrome-related enzymes, including pancreatic lipase, α-amylase, α-glucosidase, and ACE. However, simulated gastrointestinal digestion reduced phytochemical content and enzyme inhibitory activity, although some bioactivity remained in the dialysate fraction, indicating potential bioavailability. This result could serve as a reference for subsequent animal or human trials on tamarillo extracts. These findings highlight the functional potential of tamarillo as a natural source of bioactive compounds for MetS prevention. Future research should focus on enhancing the stability and bioavailability of tamarillo phytochemicals, such as through encapsulation technologies or food matrix integration, to maximize their health benefits in functional food applications.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Table S1. The extraction yields of freeze-dried extracts. Figure S1. Scavenging ability on 2,2-diphenyl-1-picrylhydrazyl radicals and reducing power of freeze-dried extracts from freeze-dried tamarillo peel, pulp, mucilage, seed and whole fruit. Figure S2. Inhibitory effects of freeze-dried extracts from freeze-dried tamarillo peel, pulp, mucilage, seed and whole fruit against pancreatic lipase. Figure S3. Inhibitory effects of freeze-dried extracts from freeze-dried tamarillo peel, pulp, mucilage, seed and whole fruit against α-amylase. Figure S4. Inhibitory effects of freeze-dried extracts from freeze-dried tamarillo peel, pulp, mucilage, seed and whole fruit against α-glucosidase. Figure S5. Inhibitory effects of freeze-dried extracts from freeze-dried tamarillo peel, pulp, mucilage, seed and whole fruit against angiotensin converting enzyme.

Author Contributions

Conceptualization, S.Y.C. and S.D.L.; Data curation, S.Y.C., Q.F.Z., H.S.S, and S.D.L.; Formal analysis, S.Y.C., Q.F.Z., H.S.S, and S.D.L.; Funding acquisition, S.D.L.; Investigation, S.Y.C., Q.F.Z. and S.D.L; Methodology, S.Y.C., Q.F.Z., H.S.S, and S.D.L.; Project administration, S.D.L.; Supervision, S.D.L.; Visualization, S.Y.C.; Writing - original draft, S.Y.C.; Writing - review & editing, S.D.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Science and Technology Council, Taiwan (MOST 107-2221-E-241-006).

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
DPPH 2,2-diphenyl-1-picrylhydrazyl
MetS metabolic syndrome
ACE angiotensin-converting enzyme
BHA butylated hydroxyanisole
EC50 the median effective concentration
IC₅₀ the half-maximal inhibitory concentration

References

  1. Saklayen, M.G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 2018, 20, 12. [Google Scholar] [CrossRef] [PubMed]
  2. Noubiap, J.J.; Nansseu, J.R.; Lontchi-Yimagou, E.; Nkeck, J.R.; Nyaga, U.F.; Ngouo, A.T.; Tounouga, D.N.; Tianyi, F.-L.; Foka, A.J.; Ndoadoumgue, A.L.; et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res. Clin. Pract. 2022, 188, 109924. [Google Scholar] [CrossRef] [PubMed]
  3. Swarup, S.; Goyal, A.; Grigorova, Y.; Zeltser, R. Metabolic syndrome. In StatPearls [Internet], StatPearls Publishing: Treasure Island (FL), 2025.
  4. Engin, A. The definition and prevalence of obesity and metabolic syndrome: correlative clinical evaluation based on phenotypes. Adv. Exp. Med. Biol. 2024, 1460, 1–25. [Google Scholar] [CrossRef]
  5. Taiwan Ministry of Health and Welfare 2023 Cause of Death Statistics. Available online: https://www.mohw.gov.tw/cp-7162-79789-2.html (accessed on 26 February 2025).
  6. Noce, A.; Di Lauro, M.; Di Daniele, F.; Pietroboni Zaitseva, A.; Marrone, G.; Borboni, P.; Di Daniele, N. Natural bioactive compounds useful in clinical management of metabolic syndrome. Nutrients 2021, 13, 630. [Google Scholar] [CrossRef]
  7. Francini, F.-P.; Spinella, P.; Calò, L.A. Potential role of phytochemicals in metabolic syndrome prevention and therapy. Diabetes Metab. Syndr. Obes. 2019, 12, 1987–2002. [Google Scholar] [CrossRef]
  8. Samtiya, M.; Aluko, R.E.; Dhewa, T.; Moreno-Rojas, J.M. Potential health benefits of plant food-derived bioactive components: An overview. Foods 2021, 10, 839. [Google Scholar] [CrossRef]
  9. Kıran, T.R.; Otlu, O.; Karabulut, A.B. Oxidative stress and antioxidants in health and disease. J. Lab. Med. 2023, 47, 1–11. [Google Scholar] [CrossRef]
  10. Vajdi, M.; Karimi, A.; Tousi, A.Z.; Hosseini, B.; Nikniaz, Z.; Farhangi, M.A. Association between plant-based diets and metabolic syndrome in obese adults from iran: A cross-sectional study. BMC Endocr. Disord. 2023, 23, 109. [Google Scholar] [CrossRef]
  11. Scaglione, S.; Di Chiara, T.; Daidone, M.; Tuttolomondo, A. Effects of the Mediterranean diet on the components of metabolic syndrome concerning the cardiometabolic risk. Nutrients 2025, 17, 358. [Google Scholar] [CrossRef]
  12. Gasmi, A.; Mujawdiya, P.K.; Noor, S.; Lysiuk, R.; Darmohray, R.; Piscopo, S.; Lenchyk, L.; Antonyak, H.; Dehtiarova, K.; Shanaida, M.; et al. Polyphenols in metabolic diseases. Molecules 2022, 27, 6280. [Google Scholar] [CrossRef]
  13. Ortega-Regules, A.E.; Martínez-Thomas, J.A.; Schürenkämper-Carrillo, K.; de Parrodi, C.A.; López-Mena, E.R.; Mejía-Méndez, J.L.; Lozada-Ramírez, J.D. Recent advances in the therapeutic potential of carotenoids in preventing and managing metabolic disorders. Plants 2024, 13, 1584. [Google Scholar] [CrossRef] [PubMed]
  14. Chen, X.; Fedrizzi, B.; Kilmartin, P.A.; Quek, S.Y. Free and glycosidic volatiles in tamarillo (Solanum betaceum Cav. Syn. Cyphomandra betacea Sendt.) juices prepared from three cultivars grown in New Zealand. J. Agric. Food Chem. 2021, 69, 4518–4532. [Google Scholar] [CrossRef] [PubMed]
  15. Diep, T.T.; Rush, E.C.; Yoo, M.J.Y. Tamarillo (Solanum betaceum Cav.): A review of physicochemical and bioactive properties and potential applications. Food Rev. Int. 2022, 38, 1343–1367. [Google Scholar] [CrossRef]
  16. Wang, S.; Zhu, F. Tamarillo (Solanum betaceum): Chemical composition, biological properties, and product innovation. Trends Food Sci. Technol. 2020, 95, 45–58. [Google Scholar] [CrossRef]
  17. Diep, T.; Pook, C.; Yoo, M. Phenolic and anthocyanin compounds and antioxidant activity of tamarillo (Solanum betaceum Cav.). Antioxidants 2020, 9, 169. [Google Scholar] [CrossRef]
  18. Machado, A.M.R.; Teodoro, A.J.; Mariutti, L.R.B.; da Fonseca, J.C.N. Tamarillo (Solanum betaceum Cav.) wastes and by-products: bioactive composition and health benefits. Heliyon 2024, 10, e37600. [Google Scholar] [CrossRef]
  19. Chen, S.-Y.; Zhang, Q.-F.; Lin, S.-D. Nutritional and phytochemical composition of the red tamarillo grown in Taiwan. J. Food Compost. Anal. 2024, 131, 106258. [Google Scholar] [CrossRef]
  20. Coimbra, P.P.S.; Silva-E-Silva, A.C.A.G.D.; Antonio, A.D.S.; Pereira, H.M.G.; Veiga-Junior, V.F.D.; Felzenszwalb, I.; Araujo-Lima, C.F.; Teodoro, A.J. Antioxidant capacity, antitumor activity and metabolomic profile of tamarillo (Solanum betaceum). Int. J. Food Sci. Technol. 2024, 59, 6267–6276. [Google Scholar] [CrossRef]
  21. Kumar, A.; P, N.; Kumar, M.; Jose, A.; Tomer, V.; Oz, E.; Proestos, C.; Zeng, M.; Elobeid, T.; K, S.; et al. Major phytochemicals: recent advances in health benefits and extraction method. Molecules 2023, 28, 887. [Google Scholar] [CrossRef]
  22. Gunathilake, K.D.P.P.; Ranaweera, K.K.D.S.; Rupasinghe, H.P.V. Change of phenolics, carotenoids, and antioxidant capacity following simulated gastrointestinal digestion and dialysis of selected edible green leaves. Food Chem. 2018, 245, 371–379. [Google Scholar] [CrossRef]
  23. Vasco, C.; Avila, J.; Ruales, J.; Svanberg, U.; Kamal-Eldin, A. Physical and chemical characteristics of golden-yellow and purple-red varieties of tamarillo fruit (Solanum betaceum Cav.). Int. J. Food Sci. Nutr. 2009, 60, 278–288. [Google Scholar] [CrossRef] [PubMed]
  24. Mau, J.-L.; Lee, C.-C.; Chen, Y.-P.; Lin, S.-D. Physicochemical, antioxidant and sensory characteristics of chiffon cake prepared with black rice as replacement for wheat flour. LWT 2017, 75, 434–439. [Google Scholar] [CrossRef]
  25. Shao, Y.; Xu, F.; Sun, X.; Bao, J.; Beta, T. Phenolic acids, anthocyanins, and antioxidant capacity in rice (Oryza sativa L.) grains at four stages of development after flowering. Food Chem. 2014, 143, 90–96. [Google Scholar] [CrossRef]
  26. Knockaert, G.; Lemmens, L.; Van Buggenhout, S.; Hendrickx, M.; Van Loey, A. Changes in β-carotene bioaccessibility and concentration during processing of carrot puree. Food Chem. 2012, 133, 60–67. [Google Scholar] [CrossRef]
  27. Shimada, K.; Fujikawa, K.; Yahara, K.; Nakamura, T. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J. Agric. Food Chem. 1992, 40, 945–948. [Google Scholar] [CrossRef]
  28. Oyaizu, M. Studies on products of browning reaction. antioxidative activities of products of browning reaction prepared from glucosamine. Jpn. J. Nutr. Diet. 1986, 44, 307–315. [Google Scholar] [CrossRef]
  29. Mcdougall, G.J.; Stewart, D. The inhibitory effects of berry polyphenols on digestive enzymes. BioFactors 2005, 23, 189–195. [Google Scholar] [CrossRef]
  30. Luyen, N.T.; Tram, L.H.; Hanh, T.T.H.; Binh, P.T.; Dang, N.H.; Minh, C. Van; Dat, N.T. Inhibitors of α-glucosidase, α-amylase and lipase from Chrysanthemum morifolium. Phytochem. Lett. 2013, 6, 322–325. [Google Scholar] [CrossRef]
  31. Pinto, M. da S.; Ghaedian, R.; Shinde, R.; Shetty, K. Potential of cranberry powder for management of hyperglycemia using in vitro models. J. Med. Food 2010, 13, 1036–1044. [Google Scholar] [CrossRef]
  32. Chiang, Y.C.; Chen, C.L.; Jeng, T.L.; Lin, T.C.; Sung, J.M. Bioavailability of cranberry bean hydroalcoholic extract and its inhibitory effect against starch hydrolysis following in vitro gastrointestinal digestion. Food Res. Int. 2014, 64, 939–945. [Google Scholar] [CrossRef]
  33. Actis-Goretta, L.; Ottaviani, J.I.; Fraga, C.G. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J. Agric. Food Chem. 2006, 54, 229–234. [Google Scholar] [CrossRef] [PubMed]
  34. Bouayed, J.; Hoffmann, L.; Bohn, T. Total phenolics, flavonoids, anthocyanins and antioxidant activity following simulated gastro-intestinal digestion and dialysis of apple varieties: Bioaccessibility and potential uptake. Food Chem. 2011, 128, 14–21. [Google Scholar] [CrossRef]
  35. McDougall, G.J.; Fyffe, S.; Dobson, P.; Stewart, D. Anthocyanins from red cabbage – stability to simulated gastrointestinal digestion. Phytochemistry 2007, 68, 1285–1294. [Google Scholar] [CrossRef] [PubMed]
  36. Plaskova, A.; Mlcek, J. New insights of the application of water or ethanol-water plant extract rich in active compounds in food. Front. Nutr. 2023, 10, 1–23. [Google Scholar] [CrossRef]
  37. Liu, Y.; Benohoud, M.; Galani Yamdeu, J.H.; Gong, Y.Y.; Orfila, C. Green extraction of polyphenols from citrus peel by-products and their antifungal activity against Aspergillus flavus. Food Chem. X 2021, 12, 100144. [Google Scholar] [CrossRef]
  38. Lim, K.J.A.; Cabajar, A.A.; Lobarbio, C.F.Y.; Taboada, E.B.; Lacks, D.J. Extraction of bioactive compounds from mango (Mangifera indica L. var. carabao) seed kernel with ethanol–water binary solvent systems. J. Food Sci. Technol. 2019, 56, 2536–2544. [Google Scholar] [CrossRef]
  39. Espin, S.; Gonzalez-Manzano, S.; Taco, V.; Poveda, C.; Ayuda-Durán, B.; Gonzalez-Paramas, A.M.; Santos-Buelga, C. Phenolic composition and antioxidant capacity of yellow and purple-red Ecuadorian cultivars of tree tomato (Solanum betaceum Cav.). Food Chem. 2016, 194, 1073–1080. [Google Scholar] [CrossRef]
  40. de Rosso, V.V.; Mercadante, A.Z. HPLC–PDA–MS/MS of anthocyanins and carotenoids from dovyalis and tamarillo fruits. J. Agric. Food Chem. 2007, 55, 9135–9141. [Google Scholar] [CrossRef]
  41. Mertz, C.; Brat, P.; Caris-Veyrat, C.; Gunata, Z. Characterization and thermal lability of carotenoids and vitamin C of tamarillo fruit (Solanum betaceum Cav.). Food Chem. 2010, 119, 653–659. [Google Scholar] [CrossRef]
  42. Rito, M.; Marques, J.; da Costa, R.M.F.; Correia, S.; Lopes, T.; Martin, D.; Canhoto, J.M.P.L.; Batista de Carvalho, L.A.E.; Marques, M.P.M. Antioxidant potential of tamarillo fruits—chemical and infrared spectroscopy analysis. Antioxidants 2023, 12, 536. [Google Scholar] [CrossRef]
  43. Zhu, G.; Fang, Q.; Zhu, F.; Huang, D.; Yang, C. Structure and function of pancreatic lipase-related protein 2 and its relationship with pathological states. Front. Genet. 2021, 12, 1–7. [Google Scholar] [CrossRef]
  44. He, X.; Chen, L.; Pu, Y.; Wang, H.; Cao, J.; Jiang, W. Fruit and vegetable polyphenols as natural bioactive inhibitors of pancreatic lipase and cholesterol esterase: Inhibition mechanisms, polyphenol influences, application challenges. Food Biosci. 2023, 55, 103054. [Google Scholar] [CrossRef]
  45. Lee, E.H.; Hong, S.-C.; Kim, S.M.; Pan, C.-H. Inhibitory effect of anthocyanin-enriched fractions from colored potatoes against lipase and α-glucosidase. LWT 2023, 184, 114952. [Google Scholar] [CrossRef]
  46. Nowicka, P.; Wojdyło, A.; Tkacz, K.; Turkiewicz, I.P. quantitative and qualitative determination of carotenoids and polyphenolics compounds in selected cultivars of Prunus persica L. and their ability to in vitro inhibit lipoxygenase, cholinoesterase, α-amylase, α-glucosidase and pancreatic lipase. Food Chem. X 2023, 17, 100619. [Google Scholar] [CrossRef]
  47. Dechakhamphu, A.; Wongchum, N. Screening for anti-pancreatic lipase properties of 28 traditional Thai medicinal herbs. Asian Pac. J. Trop. Biomed. 2015, 5, 1042–1045. [Google Scholar] [CrossRef]
  48. Ibrahim, M.A.; Bester, M.J.; Neitz, A.W.; Gaspar, A.R.M. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates. Biomed. Pharmacother. 2018, 107, 234–242. [Google Scholar] [CrossRef] [PubMed]
  49. You, Q.; Chen, F.; Wang, X.; Jiang, Y.; Lin, S. Anti-diabetic activities of phenolic compounds in muscadine against alpha-glucosidase and pancreatic lipase. LWT 2012, 46, 164–168. [Google Scholar] [CrossRef]
  50. Peng, X.; Zhang, G.; Liao, Y.; Gong, D. Inhibitory kinetics and mechanism of kaempferol on α-glucosidase. Food Chem. 2016, 190, 207–215. [Google Scholar] [CrossRef]
  51. Aleixandre, A.; Gil, J.V.; Sineiro, J.; Rosell, C.M. Understanding phenolic acids inhibition of α-amylase and α-glucosidase and influence of reaction conditions. Food Chem. 2022, 372, 131231. [Google Scholar] [CrossRef]
  52. Xu, C.; He, M.; Jiang, Z.; Yang, Q. Inhibition mechanism of buckwheat hulls polyphenols on α-amylase and α-glucosidase using kinetics, spectroscopics and molecular docking approaches. Int. J. Biol. Macromol. 2024, 280, 136046. [Google Scholar] [CrossRef]
  53. Gopal, S.S.; Lakshmi, M.J.; Sharavana, G.; Sathaiah, G.; Sreerama, Y.N.; Baskaran, V. Lactucaxanthin – a potential anti-diabetic carotenoid from lettuce (Lactuca sativa) inhibits α-amylase and α-glucosidase activity in vitro and in diabetic rats. Food Funct. 2017, 8, 1124–1131. [Google Scholar] [CrossRef]
  54. Ghani, U. Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. Eur. J. Med. Chem. 2015, 103, 133–162. [Google Scholar] [CrossRef] [PubMed]
  55. Oboh, G.; Ogunsuyi, O.B.; Ogunbadejo, M.D.; Adefegha, S.A. Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose. J. Food Drug Anal. 2016, 24, 627–634. [Google Scholar] [CrossRef] [PubMed]
  56. Fountain, J.H.; Kaur, J.; Lappin, S.L. Physiology, Renin Angiotensin System. In StatPearls [Internet], StatPearls Publishing: Treasure Island (FL), 2025.
  57. Yamane, T. Chapter 8 - Beneficial effects of anthocyanin from natural products on lifestyle-related diseases through inhibition of protease activities. In Studies in Natural Products Chemistry, Atta-ur-Rahman, Elsevier: Amsterdam, Netherlands, 2018; Volume 58, pp. 245–264.
  58. Abbasian, F.; Alavi, M.S.; Roohbakhsh, A. Dietary carotenoids to improve hypertension. Heliyon 2023, 9, e19399. [Google Scholar] [CrossRef] [PubMed]
  59. Paiva, L.; Lima, E.; Marcone, M.; Baptista, J. Angiotensin I-converting enzyme (ACE) inhibition and biological activities of green and black tea samples from Azorean Camellia sinensis. J. Funct. Foods 2023, 107, 105701. [Google Scholar] [CrossRef]
  60. Herrera Chalé, F.G.; Ruiz Ruiz, J.C.; Acevedo Fernández, J.J.; Betancur Ancona, D.A.; Segura Campos, M.R. ACE inhibitory, hypotensive and antioxidant peptide fractions from Mucuna pruriens proteins. Process Biochem. 2014, 49, 1691–1698. [Google Scholar] [CrossRef]
  61. Gonçalves, A.; Estevinho, B.N.; Rocha, F. Methodologies for simulation of gastrointestinal digestion of different controlled delivery systems and further uptake of encapsulated bioactive compounds. Trends Food Sci. Technol. 2021, 114, 510–520. [Google Scholar] [CrossRef]
  62. Dima, C.; Assadpour, E.; Dima, S.; Jafari, S.M. Bioavailability and bioaccessibility of food bioactive compounds; overview and assessment by in vitro methods. Compr. Rev. Food Sci. Food Saf. 2020, 19, 2862–2884. [Google Scholar] [CrossRef]
  63. Ketnawa, S.; Reginio Jr., F. C.; Thuengtung, S.; Ogawa, Y. Changes in bioactive compounds and antioxidant activity of plant-based foods by gastrointestinal digestion: A review. Crit. Rev. Food Sci. Nutr. 2022, 62, 4684–4705. [Google Scholar] [CrossRef]
  64. Kamiloglu, S.; Pasli, A.A.; Ozcelik, B.; Capanoglu, E. Evaluating the in vitro bioaccessibility of phenolics and antioxidant activity during consumption of dried fruits with nuts. LWT 2014, 56, 284–289. [Google Scholar] [CrossRef]
  65. Rocha, H.R.; Coelho, M.C.; Gomes, A.M.; Pintado, M.E. Carotenoids diet: Digestion, gut microbiota modulation, and inflammatory diseases. Nutrients 2023, 15, 2265. [Google Scholar] [CrossRef] [PubMed]
  66. He, M.; Zeng, J.; Zhai, L.; Liu, Y.; Wu, H.; Zhang, R.; Li, Z.; Xia, E. Effect of in vitro simulated gastrointestinal digestion on polyphenol and polysaccharide content and their biological activities among 22 fruit juices. Food Res. Int. 2017, 102, 156–162. [Google Scholar] [CrossRef] [PubMed]
  67. Hwang, E.S.; Kim, S. Effect of in vitro gastrointestinal digestion on phytochemicals and antioxidant activities in cherry tomatoes (Solanum lycopersicum Var. cerasiforme). Prev. Nutr. Food Sci. 2023, 28, 312–320. [Google Scholar] [CrossRef]
  68. Liu, X.; Dong, M.; Chen, X.; Jiang, M.; Lv, X.; Yan, G. Antioxidant activity and phenolics of an endophytic Xylaria Sp. from Ginkgo biloba. Food Chem. 2007, 105, 548–554. [Google Scholar] [CrossRef]
  69. Wong, Y.-H.; Tan, C.-P.; Long, K.; Nyam, K.-L. In vitro simulated digestion on the biostability of Hibiscus cannabinus L. seed extract. Czech J. Food Sci. 2014, 32, 177–181. [Google Scholar] [CrossRef]
  70. Rocchetti, G.; Gregorio, R.P.; Lorenzo, J.M.; Barba, F.J.; Oliveira, P.G.; Prieto, M.A.; Simal-Gandara, J.; Mosele, J.I.; Motilva, M.; Tomas, M.; et al. Functional implications of bound phenolic compounds and phenolics–food interaction: A review. Compr. Rev. Food Sci. Food Saf. 2022, 21, 811–842. [Google Scholar] [CrossRef]
  71. Tarko, T.; Duda-Chodak, A.; Sroka, P.; Satora, P.; Michalik, J. Transformations of phenolic compounds in an in vitro model simulating the human alimentary tract. Food Technol. Biotechnol. 2009, 47, 456–463. [Google Scholar]
  72. Ayvaz, H.; Cabaroglu, T.; Akyildiz, A.; Pala, C.U.; Temizkan, R.; Ağçam, E.; Ayvaz, Z.; Durazzo, A.; Lucarini, M.; Direito, R.; et al. Anthocyanins: Metabolic digestion, bioavailability, therapeutic effects, current pharmaceutical/industrial use, and innovation potential. Antioxidants 2022, 12, 48. [Google Scholar] [CrossRef]
  73. Xue, H.; Sang, Y.; Gao, Y.; Zeng, Y.; Liao, J.; Tan, J. Research progress on absorption, metabolism, and biological activities of anthocyanins in berries: A review. Antioxidants 2022, 12, 3. [Google Scholar] [CrossRef]
  74. Yamazaki, M.; Nakajima, J.; Yamanashi, M.; Sugiyama, M.; Makita, Y.; Springob, K.; Awazuhara, M.; Saito, K. Metabolomics and differential gene expression in anthocyanin chemo-varietal forms of Perilla frutescens. Phytochemistry 2003, 62, 987–995. [Google Scholar] [CrossRef]
  75. Maurya, V.K.; Singh, J.; Ranjan, V.; Gothandam, K.M.; Bohn, T.; Pareek, S. Factors affecting the fate of β-carotene in the human gastrointestinal tract: A narrative review. Int. J. Vitam. Nutr. Res. 2022, 92, 385–405. [Google Scholar] [CrossRef] [PubMed]
  76. Hu, Y.; Lin, Q.; Zhao, H.; Li, X.; Sang, S.; McClements, D.J.; Long, J.; Jin, Z.; Wang, J.; Qiu, C. Bioaccessibility and bioavailability of phytochemicals: Influencing factors, improvements, and evaluations. Food Hydrocoll. 2023, 135, 108165. [Google Scholar] [CrossRef]
  77. Dacoreggio, M.V.; Santetti, G.S.; Inácio, H.P.; da Silva Haas, I.C.; da Silva Monteiro Wanderley, B.R.; Hoff, R.B.; Freire, C.B.F.; Kempka, A.P.; de Mello Castanho Amboni, R.D. Exploring the effects of gastrointestinal digestion on phenolic profile and antioxidant activity: A new perspective on the biological potential of infusion of Eugenia pyriformis Cambess leaves. Meas.: Food 2024, 14, 100167. [Google Scholar] [CrossRef]
  78. Sánchez-Velázquez, O.A.; Mulero, M.; Cuevas-Rodríguez, E.O.; Mondor, M.; Arcand, Y.; Hernández-Álvarez, A.J. In vitro gastrointestinal digestion impact on stability, bioaccessibility and antioxidant activity of polyphenols from wild and commercial blackberries (Rubus Spp.). Food Funct. 2021, 12, 7358–7378. [Google Scholar] [CrossRef]
Figure 1. Total phenols, total anthocyanins and total carotenoids content of freeze-dried extracts. Each value is expressed as mean ± standard deviation (n = 3). Means with different capital letters from the same fruit part extracted with different solvents differ significantly different (p < 0.05). Means with different lowercase letters from the extracts of different fruit parts using the same solvent differ significantly (p < 0.05).
Figure 1. Total phenols, total anthocyanins and total carotenoids content of freeze-dried extracts. Each value is expressed as mean ± standard deviation (n = 3). Means with different capital letters from the same fruit part extracted with different solvents differ significantly different (p < 0.05). Means with different lowercase letters from the extracts of different fruit parts using the same solvent differ significantly (p < 0.05).
Preprints 152578 g001
Table 1. Hydroxycinnamoyl derivatives, anthocyanins and carotenoids content of freeze-dried extracts.
Table 1. Hydroxycinnamoyl derivatives, anthocyanins and carotenoids content of freeze-dried extracts.
P95E1 L95E M95E S75E W95E
Hydroxycinnamoyl derivatives (mg/g freeze-dried extract)
Chlorogenic acid 74.90 ± 0.850 Aa2 5.707 ± 0.082 Ac 1.696 ± 0.075 Ad 1.868 ± 0.064 Ad 9.234 ± 0.103 Ab
Rosmarinic acid 66.69 ± 0.090 Ba 3.227 ± 0.072 Bc 0.242 ± 0.001 Be 1.544 ± 0.043 Bd 6.697 ± 0.070 Bb
Total 141.6 ± 0.800 a 8.934 ± 0.154 c 1.938 ± 0.076 e 3.412 ± 0.106 d 15.93 ± 0.170 b
Anthocyanins (mg/g freeze-dried extract)
Delphinidin-3-O-rutinoside 0.659 ± 0.006 Cd 0.253 ± 0.008 Be 6.606 ± 0.101Aa 4.179 ± 0.062 Ab 2.186 ± 0.004 Ac
Pelargonidin-3-O-rutinoside 1.291 ± 0.007 Bd 0.311 ± 0.001 Ae 6.111 ± 0.084 Ba 3.116 ± 0.151 Bb 2.055 ± 0.022 Bc
Cyanidin-3-O-rutinoside 8.687 ± 0.116 Aa 0.061 ± 0.007 Cd 0.675 ± 0.069Cb 0.336 ± 0.013 Cc 0.763 ± 0.001 Cb
Total 10.64 ± 0.120 b 0.625 ± 0.014 e 13.39 ± 0.086 a 7.630 ± 0.077 c 5.005 ± 0.027 d
Carotenoids (mg/g freeze-dried extract)
Zeaxanthin 0.073 ± 0.003 Ba2 0.006 ±< 0.001 Cc nd 0.009 ±< 0.001Bbc 0.014 ± 0.004 Cb
β-Cryptoxanthin 0.928 ± 0.020 Aa 0.240 ±< 0.001 Ab 0.085 ± 0.006 Ac 0.061 ±< 0.001 Ad 0.238 ± 0.004 Ab
Lycopene nd3 nd nd nd nd
α-Carotene nd nd nd nd nd
β-Carotene 0.942 ± 0.020 Aa 0.184 ± 0.008 Bb 0.051 ± 0.006 Bc nd 0.066 ± 0.005 Bc
Total 1.943 ± 0.044 a 0.431 ± 0.009 b 0.136 ± 0.012 d 0.069 ± 0.001 e 0.318 ± 0.005 c
1P95E, L95E, M95E and W95E: the freeze-dried extracts were prepared from freeze-dried tamarillo peel, pulp, mucilage and whole fruit with 95% ethanol at 75 °C in a shaking water bath (150 rpm), respectively. S75E, the freeze-dried extracts were prepared from freeze-dried tamarillo seed with 75% ethanol at 75 °C in a shaking water bath (150 rpm). 2Each value is expressed as mean ± standard deviation (n = 3). Means with different capital letters within a column differ significantly (p < 0.05). Means with different lowercase letters within a row differ significantly (p < 0.05).
Table 2. EC50 values of freeze-dried extracts for scavenging ability on 2,2-diphenyl-1-picrylhydrazyl radicals and reducing power.
Table 2. EC50 values of freeze-dried extracts for scavenging ability on 2,2-diphenyl-1-picrylhydrazyl radicals and reducing power.
Extraction method EC50 value of scavenging ability2 EC50 value of reducing power3
Extract (μg extract/mL) Extract (μg total phenols/mL) Extract (μg extract/mL) Extract (μg total phenols/mL)
P95E1 45.26 ± 0.11 D4 9.420 ± 0.18 E 113.3 ± 1.0 E 23.58 ± 0.72 D
L95E 388.2 ± 4.5 A 15.57 ± 0.42 A 956.7 ± 8.2 A 38.37 ± 0.91 A
M95E 386.4 ± 4.2 A 14.93 ± 0.05 B 938.4 ± 5.1 B 36.26 ± 0.47 B
S75E 181.6 ± 2.3 C 10.27 ± 0.06 D 597.2 ± 1.4 D 33.77 ± 0.69 C
W95E 221.0 ± 2.7 B 12.24 ± 0.04 C 618.8 ± 4.3 C 34.27 ± 0.29 C
1P95E, L95E, M95E and W95E: the freeze-dried extracts were prepared from freeze-dried tamarillo peel, pulp, mucilage and whole fruit with 95% ethanol at 75 °C in a shaking water bath (150 rpm), respectively. S75E, the freeze-dried extracts were prepared from freeze-dried tamarillo seed with 75% ethanol at 75 °C in a shaking water bath (150 rpm). 2EC50 value of scavenging ability: the effective concentration at which 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals were scavenged by 50%. EC50 value was obtained by interpolation from linear regression analysis. EC50 value of ascorbic acid, BHA and α-tocopherol were 15.60 ± 0.14, 17.51 ± 0.12 and 16.35 ± 0.10 μg/mL, respectively. 3EC50 value of reducing power: the effective concentration at which the absorbance is 0.5. EC50 value of ascorbic acid, BHA and α-tocopherol were 19.87 ± 0.03, 34.98 ± 0.55 and 118.31 ± 0.43 μg /mL, respectively. 4Each value is expressed as mean ± standard deviation (n = 3). Means with different capital letters within a column differ significantly (p < 0.05).
Table 3. IC50 values of inhibitory effects of freeze-dried extracts against pancreatic lipase, α-amylase, α-glucosidase and angiotensin converting enzyme.
Table 3. IC50 values of inhibitory effects of freeze-dried extracts against pancreatic lipase, α-amylase, α-glucosidase and angiotensin converting enzyme.
Extraction method1 IC50 values (mg/mL)2
Pancreatic lipase α-Amylase α-Glucosidase ACE3
P95E 2.964 ± 0.032 B4 5.368 ± 0.002 B 1.623 ± 0.019 E 1.435 ± 0.103 D
L95E 0.882 ± 0.007 E 2.369 ± 0.006 E 6.299 ± 0.109 B 4.038 ± 0.091 A
M95E 1.637 ± 0.002 D 3.351 ± 0.029 C 8.856 ± 0.117 A 3.587 ± 0.173 B
S75E 16.67 ± 0.290 A 14.80 ± 0.020 A 3.581 ± 0.106 D 1.471 ± 0.049 D
W95E 1.861 ± 0.030 C 3.132 ± 0.004 D 5.534 ± 0.102 C 3.349 ± 0.196 C
Orlistat (5.525 ± 0.060) × 10-3 F - - -
Acarbose - (9.121 ± 0.069) × 10-2 F (9.121 ± 0.069) × 10-2 F -
Captopril - - - (0.481 ± 0.003) × 10-6 E
1P95E, L95E, M95E and W95E: the freeze-dried extracts were prepared from freeze-dried tamarillo peel, pulp, mucilage and whole fruit with 95% ethanol at 75 °C in a shaking water bath (150 rpm), respectively. S75E, the freeze-dried extracts were prepared from freeze-dried tamarillo seed with 75% ethanol at 75 °C in a shaking water bath (150 rpm). 2 IC50 value: the enzyme activity was inhibited by 50%. The IC50 value obtained by interpolation from linear regression analysis. 3ACE: angiotensin converting enzyme. 4Each value is expressed as mean ± standard deviation (n = 3). Means with different capital letters within a column differ significantly (p < 0.05).
Table 4. Amounts of total phenols, anthocyanins and carotenoids in the tested 200 mg of tamarillo extracts before (non-digested original) and after the simulated in vitro gastrointestinal digestion.
Table 4. Amounts of total phenols, anthocyanins and carotenoids in the tested 200 mg of tamarillo extracts before (non-digested original) and after the simulated in vitro gastrointestinal digestion.
P95E4 L95E M95E S75E W95E
Total phenols (mg GAE1/200 mg freeze-dried extract)
Non-digested original 30.59 ± 0.175 a5 4.237 ± 0.030 d 3.970 ± 0.062 e 9.662 ± 0.210 b 6.928 ± 0.009 c
Sampled from intestinal phase (soluble) 34.32 ± 0.219 a 7.188 ± 0.153 d 7.113 ± 0.020 d 11.87 ± 0.270 b 10.28 ± 0.194 c
Sampled from intestinal phase (insoluble) 1.174 ± 0.033 b 1.115 ± 0.006 bc 1.115 ± 0.003 bc 1.541 ± 0.059 a 1.103 ± 0.009 c
Sampled from dialysis phase 3.168 ± 0.294 a 0.793 ± 0.010 c 0.746 ± 0.037 c 1.146 ± 0.033 b 1.025 ± 0.027 bc
Total anthocyanins (mg C3GE2/ 200 mg freeze-dried extract)
Non-digested original 1.120 ± 0.013 b 0.222 ± 0.002 e 1.628 ± 0.032 a 0.437 ± 0.021 d 0.735 ± 0.002 c
Sampled from intestinal phase (soluble) 0.589 ± 0.014 b nd 1.406 ± 0.015 a nd nd
Sampled from intestinal phase (insoluble) nd6 nd nd nd nd
Sampled from dialysis phase 0.176 ± 0.015 b 0.021 ± 0.008 d 0.267 ± 0.015 a 0.063 ± 0.013 c 0.068 ± 0.016 c
Total carotenoids (mg βCE3/200 mg freeze-dried extract)
Non-digested original 0.865 ± 0.029 a 0.235 ± 0.010 b 0.093 ± 0.004 e 0.186 ± 0.016 c 0.154 ±< 0.001 d
Sampled from intestinal phase (soluble) 0.435 ± 0.022 a 0.157 ± 0.021 b 0.049 ± 0.022 d 0.038 ± 0.012 d 0.082 ± 0.020 c
Sampled from intestinal phase (insoluble) 0.067 ± 0.029 a 0.016 ± 0.005 b 0.004 ± 0.001 b 0.004 ± 0.003 b 0.003 ± 0.002 b
Sampled from dialysis phase 0.081 ± 0.004 a 0.024 ± 0.010 b 0.016 ± 0.004 b 0.020 ± 0.015 b 0.027 ± 0.002 b
1GAE꞉ Gallic acid equivalent. It estimated concentration of 152.96, 21.19, 19.85, 48.31 and 34.64 mg total phenols g−1 dry weight extract. 2C3GE: cyanidin-3-O-glucoside equivalent. It estimated concentration of 5.60, 1.11, 8.14, 2.18 and 3.67 mg total anthocyanins g−1 dry weight extract 3βCE: β-carotene equivalent. It estimated concentration of 4.32, 1.17, 0.47, 0.93 and 0.77 mg total carotenoids g−1 dry weight extract 4P95E, L95E, M95E and W95E: the samples were prepared from freeze-dried tamarillo peel, pulp, mucilage, and whole fruit extracts before and after in vitro gastrointestinal digestion simulation. 5Each value is expressed as mean ± standard deviation (n = 3). Means with different lowercase letters within a row differ significantly (p < 0.05). 6nd: not detectable.
Table 5. Amounts of IC50 values of inhibitory against pancreatic lipase, α-amylase, α-glucosidase and angiotensin converting enzyme in the tested 200 mg extracts before (non-digested original) and after the simulated in vitro gastrointestinal digestion (GD).
Table 5. Amounts of IC50 values of inhibitory against pancreatic lipase, α-amylase, α-glucosidase and angiotensin converting enzyme in the tested 200 mg extracts before (non-digested original) and after the simulated in vitro gastrointestinal digestion (GD).
Sampled from dialysis phase1 IC50 values (mg/mL)2
Pancreatic lipase α-Amylase α-Glucosidase ACE3
P95E Before GD 2.964 ± 0.032 B4 5.368 ± 0.002 B 1.623 ± 0.019 E 1.435 ± 0.103 C
After GD 24.72 ± 1.650 b 46.00 ± 0.170 b 13.23 ± 0.050 d 12.87 ± 0.890 b
L95E Before GD 0.882 ± 0.0070 D 2.369 ± 0.006 E 6.299 ± 0.109 B 4.038 ± 0.091 A
After GD 4.369 ± 0.077 d 12.42 ± 0.990 e 30.90 ± 0.990 b 20.45 ± 0.980 a
M95E Before GD 1.637 ± 0.002 C 3.351 ± 0.029 C 8.856 ± 0.117 A 3.587 ± 0.173 B
After GD 8.028 ± 0.187 cd 16.52 ± 0.270 d 44.88 ± 0.660 a 18.92 ± 1.750 a
S75E Before GD 16.66 ± 0.290 A 14.80 ± 0.020 A 3.581 ± 0.106 D 1.471 ± 0.049 C
After GD 109.1 ± 5.490 a 95.77 ± 3.210 a 24.76 ± 4.060 c 9.567 ± 0.612 c
W95E Before GD 1.861 ± 0.030 C 3.132 ± 0.004 D 5.534 ± 0.102 C 3.349 ± 0.196 B
After GD 11.44 ± 0.540 c 20.04 ± 0.730 c 32.00 ± 0.340 b 20.58 ± 2.140 a
1The samples were in the dialysis phase after simulated digestion. 2IC50 value: the enzyme activity was inhibited by 50%. The IC50 value obtained by interpolation from linear regression analysis. 3ACE: angiotensin converting enzyme. 4Each value is expressed as mean ± standard deviation (n = 3). Means with different letters (a, b, c or A, B, C) within a column differ significantly (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated